Stocktoria

NewGenIvf Group Ltd NIVF

Nasdaq · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2022-02-15

NewGenIvf Group Ltd statistics & valuation

Market cap$5.6M
P / E0.6×
P / S0.2×
P / B0.2×
Net margin41.7%
Return on equity37.1%
FCF margin-46.7%
Return on capital-35.3%
Graham number +4419.8%$23.67

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($23.67); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
7.70% 2.50% -9.70% 41.70% 2022202320242025
Gross margin (%)
25.90% 32.70% 33.60% 4.00% 2022202320242025
Operating margin (%)
6.70% 0.80% -21.40% -45.20% 2022202320242025
Return on equity (%)
81.50% 3.50% 37.10% 2022202320242025
Shares outstanding
601830 507469 380 3.3M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
15.80% 2.90% -14.70% 30.20% 2022202320242025
Free cash flow margin (%)
27.20% -35.70% -153.10% -46.70% 2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
$4.72 $13019.30 -$4408.76 $3.04 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin4.0%33.6%32.7%25.9%
Operating margin-45.2%-21.4%0.8%6.7%
Net margin41.7%-9.7%2.5%7.7%
FCF margin-46.7%-153.1%-35.7%27.2%
Return on assets30.2%-14.7%2.9%15.8%
Return on equity37.1%35.4%3.5%81.5%
Current ratio3.121.172.190.94

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.